Adocia's $1.8B Claim Against Eli Lilly Dies In Arbitration
An American Arbitration Association tribunal has tossed French biopharmaceutical company Adocia SA's arbital claim seeking $1.8 billion in damages against Eli Lilly & Co. over the U.S. drugmaker's alleged misappropriation of...To view the full article, register now.
Already a subscriber? Click here to view full article